-+ 0.00%
-+ 0.00%
-+ 0.00%

Everest Medicines files board, board committee member list with disclosure responsibilities

PUBT·08/14/2026 09:06:45
Listen to the news
Everest Medicines files board, board committee member list with disclosure responsibilities
  • Everest Medicines updated its board and committee roster, naming Wu Yifang as chairman, Luo Yongqing as CEO, He Ying as president and CFO.
  • Fu Wei serves as honorary chairman; Sun Xin, Wang Yue serve as non-executive directors.
  • Independent non-executive directors include Xu Haiyin, Li Yifan, Jiang Shidong.
  • Audit committee chaired by Li Yifan; members include Xu Haiyin, Jiang Shidong.
  • Nomination committee chaired by Wu Yifang; remuneration committee chaired by Xu Haiyin; disclosure dated Aug. 14, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everest Medicines Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260814-12284582), on August 14, 2026, and is solely responsible for the information contained therein.